top of page
HOME_banner.jpg

CYTORA is a clinical stage stem cell company developing a new class of

medicines  based on a novel and transformative  patented
platform
stem cell technology derived from unique

human Oral Mucosa Stem Cells (hOMSC).
 

scientist-pipetting-stem-cells-in-tubes-2022-01-19-00-27-44-utc (1).jpg

OUR SOLUTION

human Oral Mucosa Stem Cells

A unique phenomenon occurs in the mouth. 

Rapid Wound Healing compared to
other tissues.

No scars!  - Full regeneration.

Regeneration is not affected by age!

This pattern of wound healing is negligibly affected by diabetes. 

2 weeks later

TECHNOLOGY

Novel and Unique

Cytora’s patented and transformative platform stem cell technology is based on the discovery of a novel and unique stem cell population in the oral mucosa termed “human Oral Mucosa Stem Cells (hOMSC)”.

APPLICATIONS

Under Clinical Development

Diabetic Wound Healing - Incurable Diabetic Foot Ulcer (IDFU) - Clinical Studies in Progress.

​

Central & Autonomic Nervous System - Multiple System Atrophy (MSA) - Clinical Studies in progress.

​

Our Team_orange banner.jpg
Home circle.png

Our Team

Highly qualified, deeply scientific team with years of research, patents and industry experience in the fields of biotechnology and stem cell therapy.

​

World renowned, expert scientific advisory board - Leading clinical experts in their respective fields.

​

CY-logo-Final-cmyk.png

Cytora is on a mission to make it standard practice for people to be treated with off-the-shelf (allogeneic) Stem Cell medicines, derived from the readily accessible oral mucosa termed human oral mucosa stem cells - hOMSC, for some of the toughest diseases within this decade, including Parkinson’s, Multiple System Atrophy (MSA), Alzheimer’s Dementia, and non-healing diabetic wounds (IDFU).

CONTACT

​

info@cytorastem.com

© 2022 Cytora. All rights reserved.

  • Twitter
  • LinkedIn
bottom of page